MAY 6, 2023 Saturday , 3rd DAY |
|||||||
VIP HALL |
HALL B (HEKİM HACI PAŞA CONFERENCE HALL) |
HALL C |
|||||
SESSION X: Nanomedicines and Nanomaterials CHAIRS: |
SESSION XI: Drug Design, Synthesis and Development CHAIRS: |
|
|||||
Prof. Emel Öykü ÇETİN UYANIKGİL, Ph.D. (Ege University, Türkiye) |
Assoc. Prof. Gülşah Erel AKBABA, Ph.D. (İzmir Katip Çelebi University, Türkiye) |
Prof. Rahime ŞİMŞEK, Ph.D. (Hacettepe University, Türkiye) |
Prof. Seda ÜNSALAN Ph.D. (Medipol University, Türkiye) |
||||
09:30-10:00 |
Prof. İhsan GÜRSEL, Ph.D. (IL-19) (Izmir Biomedicine and Genome Center, Türkiye) “Design characterization and in vivo performance of VLP Vaccine against SARS-CoV-2” |
09:30-10:00 |
Prof. Soodabeh Davaran, Ph.D. (IL-21) (Tabriz University of Medical Sciences, Iran) “Novel nanoparticulate system for treatment of neurodegenerative diseases” |
Oral presentations
|
|||
10:00-10:30 |
Prof. Kezban ULUBAYRAM, Ph.D. (IL-20) (Hacettepe University, Türkiye) “Advanced Biomaterials for Wound Healing and Hemostasis”
|
10:00-10:30 |
Prof. Ali ÇAĞIR, Ph.D. (IL-22) (IZTECH, Türkiye) “Investigation of the antiproliferative activities of intermediate and side products of ezetimibe synthesis in cancer cells” |
||||
10:30-10:55 |
Assoc. Prof. Sinan GÜVEN, Ph.D. (OL-07) (Izmir Biomedicine and Genome Center, Türkiye) “Organ-on-a-chip platforms for drug screening” |
10:30-10:55 |
Assist. Prof. Abdurrahman OLGAÇ, Ph.D. (OL-08) (Gazi University, Türkiye) “A Tale of Two Diverse Sets of Novel 5-Lipoxygenase Activating Protein (FLAP) Inhibitors” |
||||
11:00-11:20 |
COFFEE BREAK |
||||||
SESSION XII: Biochemistry and Molecular Biology CHAIRS: |
SESSION XIII: Pharmaceutical Technology, Pharmaceutical Biotechnology and Radiopharmacy CHAIRS: |
|
|||||
Prof. Güliz ARMAĞAN, Ph.D. (Ege University, Türkiye) |
Prof. Sinem Ezgi TURUNÇ ÖZOĞLU, Ph.D. (İzmir Katip Çelebi University, Türkiye) |
Prof. Evren ATLIHAN GÜNDOĞDU, Ph.D., (Ege University, Türkiye) |
Prof. Zeynep ŞENYİĞİT, Ph.D. (İzmir Katip Çelebi University, Türkiye) |
||||
11:20-11:45 |
Prof. Luciano SASO, Ph.D. (IL-23) (Sapienza University of Rome, Italy) “Pharmacological modulation of oxidative stress”-(Online) |
11:20-11:45 |
Dr. Sylvie CHALON, Ph.D. (IL-25) (University of Tours, France) “Radiotracers for imaging of neurodegenerative diseases”-(Online) |
Oral presentations
|
|||
11:45-12:15 |
Prof. Hülya AYAR KAYALI, Ph.D. (IL-24) (Izmir Biomedicine and Genome Center, Türkiye) “Production and Characterisation of Therapeutic Monoclonal Antibodies” |
11:45-12:15 |
Prof. Hatice Yeşim KARASULU Ph.D. (IL-26) (Ege University, Türkiye) “Oral Lipid Based Drug Delivery Systems with Recent Scientific And Regulatory Approaches” |
||||
12:15-12:40 |
Asst. Prof. Yalçın ERZURUMLU, Ph.D. (OL-09) (Süleyman Demirel University, Türkiye) “Steroidal regulation of androgenic signaling in prostate cancer: Could it offer a powerful therapeutic approach?” |
12:15-12:40 |
Assoc. Prof. Hasan AKBABA, Ph.D. (OL-10) (Ege University, Türkiye) “CRISPR-CAS9 Mediated Immune Checkpoint Gene Knockout with Targeted Nanoparticles Against Triple-Negative Breast Cancer” |
||||
12:40-13:50 |
COFFEE BREAK |
||||||
HALL A (PROF. DR. FUAT SEZGİN CONFERENCE HALL) |
HALL B (HEKİM HACI PAŞA CONFERENCE HALL) |
|
|||||
SESSION XIV: Pharmacology and Clinical Pharmacy CHAIRS: |
SESSION XV: Pharmaceutical Toxicology and Pharmaceutical Microbiology CHAIRS: |
|
|||||
Prof. Rümeysa DEMİRDAMAR, Ph.D. (European University of Lefke, TRNC) |
Prof. C. Kemal BUHARALIOĞLU, Ph.D. (İzmir Katip Çelebi University, Türkiye) |
Assist. Prof. Elif İnce ERGÜÇ, Ph.D. (İzmir Katip Çelebi University, Türkiye) |
Prof. Bayrı ERAÇ, Ph.D., (Ege University, Türkiye) |
||||
14:10-14:40 |
Prof. Şule APIKOĞLU Ph.D. (IL-27) (Marmara University, Türkiye) “Digital Healthcare Services for Drug Therapy Optimisation in the Elderly” |
14:10-14:40 |
Prof. Mert DÖŞKAYA, Ph.D. (IL-30) (Ege University, Türkiye) “Importance of Antigen Design in Nucleic Acid Vaccines: SARS-CoV-2 DNA Vaccine Experience” |
Oral presentations
|
|||
14:40-15:10 |
Prof. Seda ÜNSALAN Ph.D. (IL-28) (Medipol University, Türkiye) “Regulatory Requirements for Bioequivalence Studies” |
14:40-15:10 |
Prof. Gülfem ECE, M.D. (IL-31) (University of Health Sciences, Türkiye) “Next Generation Probiotics and Microbiota” |
||||
15:10-15:35 |
Reşat ÇINAR, Ph.D. (IL-29) (National Institutes of Health, USA) “Polypharmacology in Fibrotic Disorders: Bench to Clinic Translation of Third Generation Cannabinoid Receptor 1 (CB1R) Antagonists”-(Online) |
15:10-15:35 |
Visiting Prof. Aziz EFTEKHARI (OL-11) (Institute of Molecular Biology & Biotechnologies, Azerbaijan) “Application of nano-antioxidants against cytotoxic agents” |
||||
|
CLOSING |